Company: TYRA
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001193125-25-266967
Chunk: 6

Company: Tyra Biosciences, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 1A
Chunk 6
---
There have been no material changes to the risk factors disclosed in Item 1A of our 2024 Annual Report. 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

None.

Issuer Repurchases of Equity Securities

None.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Director and Officer Trading Arrangements

Rule 10b5-1 Trading Plans 

From time to time, our officers (as defined in Rule 16a-1(f) of the Exchange Act) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months ended September 30, 2025, none of our officers or directors adopted, modified or terminated any such trading arrangements.